CLINICAL TRIALS PROFILE FOR SUCCIMER
✉ Email this page to a colleague
All Clinical Trials for Succimer
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00004838 ↗ | Randomized Study of Succimer (Dimercaptosuccinic Acid) on Growth of Lead-Poisoned Children | Completed | Nationwide Children's Hospital | N/A | 1997-09-01 | OBJECTIVES: Compare growth of lead-poisoned children receiving succimer (dimercaptosuccinic acid; DMSA) plus standard treatment to those receiving standard treatment only. |
NCT00004838 ↗ | Randomized Study of Succimer (Dimercaptosuccinic Acid) on Growth of Lead-Poisoned Children | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | N/A | 1997-09-01 | OBJECTIVES: Compare growth of lead-poisoned children receiving succimer (dimercaptosuccinic acid; DMSA) plus standard treatment to those receiving standard treatment only. |
NCT00342849 ↗ | Treatment of Lead-Exposed Children Trial | Completed | National Institute of Environmental Health Sciences (NIEHS) | Phase 3 | 1994-07-15 | The Treatment of Lead-Exposed Children (TLC) clinical trial compared the effect of lead chelation with succimer to placebo therapy. TLC was a randomized, double-blind, placebo-controlled clinical trial with sites in Cincinnati and Columbus, Ohio, Philadelphia, Pennsylvania, Baltimore, Maryland and Newark, New Jersey. The study was designed to test outcomes in IQ, neuropsychological function, behavior, physical growth and blood pressure three years after initiation of treatment. Enrollment was conducted between 1994 and 1997, with completion of the initial three-year follow-up in 2000. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Succimer
Condition Name
Clinical Trial Locations for Succimer
Trials by Country
Clinical Trial Progress for Succimer
Clinical Trial Phase
Clinical Trial Sponsors for Succimer
Sponsor Name